Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELAS PHARMACIE DES SABLAS : revenue, balance sheet and financial ratios

SELAS PHARMACIE DES SABLAS is a French company founded 22 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in MONTAREN-ET-SAINT-MEDIERS (30700), this company of category PME shows in 2016 a revenue of 3.3 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELAS PHARMACIE DES SABLAS (SIREN 452402472)
Indicator 2021 2020 2019 2018 2017 2016
Revenue N/C N/C N/C N/C N/C 3 311 719 €
Net income 117 704 € 20 224 € 44 264 € 49 973 € 86 370 € 58 365 €
EBITDA N/C N/C N/C N/C N/C 127 831 €
Net margin N/C N/C N/C N/C N/C 1.8%

Revenue and income statement

In 2021, SELAS PHARMACIE DES SABLAS generates positive net income of 118 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2021: 58 k€ -> 118 k€.

Net income (2021) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

117 704 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 143%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 31%. The balance between equity and debt is satisfactory.

Debt ratio (2021) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

142.717%

Financial autonomy (2021) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

30.537%

Asset age ratio (2021) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

37.6%

Solvency indicators evolution
SELAS PHARMACIE DES SABLAS

Sector positioning

Debt ratio
142.72 2021
2019
2020
2021
Q1: 29.03
Med: 85.54
Q3: 208.44
Average +8 pts over 3 years

In 2021, the debt ratio of SELAS PHARMACIE DES SABLAS (142.72) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
30.54% 2021
2019
2020
2021
Q1: 25.88%
Med: 44.4%
Q3: 64.18%
Average -10 pts over 3 years

In 2021, the financial autonomy of SELAS PHARMACIE DES SABLAS (30.5%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 149.72. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2021) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

149.716

Liquidity indicators evolution
SELAS PHARMACIE DES SABLAS

Sector positioning

Liquidity ratio
149.72 2021
2019
2020
2021
Q1: 139.19
Med: 190.69
Q3: 259.61
Average +7 pts over 3 years

In 2021, the liquidity ratio of SELAS PHARMACIE DES SABLAS (149.72) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2021) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2021) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2021) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2021) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELAS PHARMACIE DES SABLAS

Positioning of SELAS PHARMACIE DES SABLAS in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 220 transactions of similar company sales in 2021, the value of SELAS PHARMACIE DES SABLAS is estimated at 1 350 113 € (range 868 129€ - 2 085 501€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2021
220 transactions
868k€ 1350k€ 2085k€
1 350 113 € Range: 868 129€ - 2 085 501€
NAF 5 année 2021

Valuation method used

Net Income Multiple
117 704 € × 11.5x = 1 350 114 €
Range: 868 130€ - 2 085 502€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELAS PHARMACIE DES SABLAS with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELAS PHARMACIE DES SABLAS

What is the revenue of SELAS PHARMACIE DES SABLAS ?

The revenue of SELAS PHARMACIE DES SABLAS in 2016 is 3.3 M€.

Is SELAS PHARMACIE DES SABLAS profitable?

Yes, SELAS PHARMACIE DES SABLAS generated a net profit of 118 k€ in 2021.

Where is the headquarters of SELAS PHARMACIE DES SABLAS ?

The headquarters of SELAS PHARMACIE DES SABLAS is located in MONTAREN-ET-SAINT-MEDIERS (30700), in the department Gard.

Where to find the tax return of SELAS PHARMACIE DES SABLAS ?

The tax return of SELAS PHARMACIE DES SABLAS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELAS PHARMACIE DES SABLAS operate?

SELAS PHARMACIE DES SABLAS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.